Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Teratogen update: valproic acid.

E J Lammer, L E Sever, G P Oakley

    Teratology
    |June 1, 1987
    PubMed
    Summary

    Valproic acid use in pregnancy significantly increases the risk of spina bifida by 1-2%. This teratogen also carries risks for minor facial malformations, necessitating informed counseling for expectant mothers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Craniosynostosis and risk factors related to thyroid dysfunction.

    American journal of medical genetics. Part A·2015
    Same author

    Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism.

    Andrology·2013
    Same author

    Increased prevalence of cardiovascular defects among 56,709 California twin pairs.

    American journal of medical genetics. Part A·2009
    Same author

    Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation.

    Journal of medical genetics·2007
    Same author

    Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995.

    Breast cancer research and treatment·2002
    Same author

    Patterns of first-year survival among infants with selected congenital anomalies in Texas, 1995-1997.

    Teratology·2001

    Area of Science:

    • Teratology
    • Obstetrics
    • Pharmacology

    Background:

    • Valproic acid is an antiepileptic drug with known risks during pregnancy.
    • Previous studies have indicated a potential link between valproic acid and birth defects.

    Purpose of the Study:

    • To quantify the risk of spina bifida associated with prenatal valproic acid exposure.
    • To evaluate the association between valproic acid and other major malformations, minor facial abnormalities, growth disturbances, and developmental disabilities.

    Main Methods:

    • Analysis of data from birth-defect monitoring programs.
    • International collaboration among monitoring program staff.

    Main Results:

    • Prenatal valproic acid exposure results in an absolute risk of 1-2% for spina bifida.
    • The risk of other major malformations is not substantially increased beyond the background risk associated with maternal epilepsy.
    • Valproic acid may cause characteristic minor facial malformations, requiring further investigation.
    • Insufficient data exists to assess risks for postnatal growth abnormalities and developmental disabilities.

    Conclusions:

    • Valproic acid is a human teratogen, with a significant risk of neural tube defects like spina bifida.
    • Informed counseling and prenatal diagnosis are crucial for pregnant individuals using valproic acid.
    • Further research is needed to fully characterize the teratogenic profile of valproic acid.

    Related Experiment Videos